Found: 30
Select item for more details and to access through your institution.
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Expression of transforming growth factor α antisense mRNA inhibits the estrogen-induced production of TGFα and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
- Published in:
- Journal of Cellular Physiology, 1993, v. 156, n. 3, p. 497, doi. 10.1002/jcp.1041560309
- By:
- Publication type:
- Article
Is there a role for adjuvant therapy in radiation-induced angiosarcoma of the breast? A case report and review of the literature.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 9, p. 4169
- By:
- Publication type:
- Article
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer.
- Published in:
- Oncogene, 2007, v. 26, n. 25, p. 3654, doi. 10.1038/sj.onc.1210381
- By:
- Publication type:
- Article
On Pure-Strategy Nash Equilibria in a Duopolistic Market Share Model.
- Published in:
- International Game Theory Review, 2019, v. 21, n. 2, p. N.PAG, doi. 10.1142/S0219198919400073
- By:
- Publication type:
- Article
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1497-0
- By:
- Publication type:
- Article
Regulation of surface-differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 4, p. 634, doi. 10.1002/ijc.2910510421
- By:
- Publication type:
- Article
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma--a pilot study.
- Published in:
- Current Oncology, 2014, v. 21, n. 3, p. 125, doi. 10.3747/co.21.1570
- By:
- Publication type:
- Article
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.
- Published in:
- Gastroenterology Research & Practice, 2018, p. 1, doi. 10.1155/2018/2373868
- By:
- Publication type:
- Article
Enhanced expression of heregulin in c- erb B-2 and c-Ha- ras transformed mouse and human mammary epithelial cells.
- Published in:
- Journal of Cellular Biochemistry, 1996, v. 60, n. 4, p. 437, doi. 10.1002/(SICI)1097-4644(19960315)60:4<437::AID-JCB1>3.0.CO;2-T
- By:
- Publication type:
- Article
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9392, doi. 10.1002/cam4.5699
- By:
- Publication type:
- Article
Geftinib: A Viewpoint by Fortunato Ciardiello.
- Published in:
- Drugs, 2002, v. 62, n. 15, p. 2249
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents.
- Published in:
- Drugs, 2000, v. 60, n. 2, p. 25, doi. 10.2165/00003495-200060001-00003
- By:
- Publication type:
- Article
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC).
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.
- Published in:
- Clinical & Experimental Immunology, 2009, v. 158, n. 1, p. 1, doi. 10.1111/j.1365-2249.2009.03992.x
- By:
- Publication type:
- Article
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1874, doi. 10.1038/bjc.2015.144
- By:
- Publication type:
- Article
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 6, p. 1168, doi. 10.1038/bjc.2014.421
- By:
- Publication type:
- Article
Comment on 'A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens'.
- Published in:
- British Journal of Cancer, 2012, v. 107, n. 10, p. 1791, doi. 10.1038/bjc.2012.431
- By:
- Publication type:
- Article
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 10, p. 1648, doi. 10.1038/bjc.2012.129
- By:
- Publication type:
- Article
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trials.
- Published in:
- Diseases of the Esophagus, 2012, v. 25, n. 2, p. 130, doi. 10.1111/j.1442-2050.2011.01220.x
- By:
- Publication type:
- Article
Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report.
- Published in:
- Targeted Oncology, 2008, v. 3, n. 4, p. 253, doi. 10.1007/s11523-008-0094-5
- By:
- Publication type:
- Article
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
- Published in:
- British Journal of Cancer, 2005, v. 92, n. 9, p. 1644, doi. 10.1038/sj.bjc.6602573
- By:
- Publication type:
- Article
Re: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: what about stage IIC?
- Published in:
- British Journal of Dermatology, 2018, v. 179, n. 6, p. 1422, doi. 10.1111/bjd.17145
- By:
- Publication type:
- Article